Integrated BioPharma, Inc. (INBP)
OTCMKTS: INBP · Delayed Price · USD
0.250
0.00 (0.00%)
May 29, 2024, 9:46 AM EDT - Market closed
Integrated BioPharma Revenue
Integrated BioPharma had revenue of $62.65M in the twelve months ending March 31, 2024, with 22.97% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $13.15M with 0.37% year-over-year growth. In the fiscal year ending June 30, 2023, Integrated BioPharma had annual revenue of $50.67M, a decrease of -9.91%.
Revenue (ttm)
$62.65M
Revenue Growth
+22.97%
P/S Ratio
0.12
Revenue / Employee
$444,312
Employees
141
Market Cap
7.52M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 50.67M | -5.57M | -9.91% |
Jun 30, 2022 | 56.25M | -7.31M | -11.51% |
Jun 30, 2021 | 63.56M | 10.79M | 20.45% |
Jun 30, 2020 | 52.77M | 2.79M | 5.59% |
Jun 30, 2019 | 49.98M | 6.27M | 14.34% |
Jun 30, 2018 | 43.71M | -3.24M | -6.91% |
Jun 30, 2017 | 46.95M | 4.74M | 11.23% |
Jun 30, 2016 | 42.21M | 4.73M | 12.61% |
Jun 30, 2015 | 37.49M | 3.81M | 11.30% |
Jun 30, 2014 | 33.68M | 60.00K | 0.18% |
Jun 30, 2013 | 33.62M | -2.98M | -8.14% |
Jun 30, 2012 | 36.60M | 11.47M | 45.64% |
Jun 30, 2011 | 25.13M | -11.89M | -32.11% |
Jun 30, 2010 | 37.02M | -2.35M | -5.96% |
Jun 30, 2009 | 39.37M | -10.57M | -21.17% |
Jun 30, 2008 | 49.94M | -10.22M | -16.99% |
Jun 30, 2007 | 60.16M | 2.34M | 4.05% |
Jun 30, 2006 | 57.82M | 25.08M | 76.63% |
Jun 30, 2005 | 32.74M | 7.45M | 29.48% |
Jun 30, 2004 | 25.28M | 3.05M | 13.71% |
Jun 30, 2003 | 22.24M | -1.31M | -5.57% |
Jun 30, 2002 | 23.55M | 8.25M | 53.97% |
Jun 30, 2001 | 15.29M | -2.68M | -14.92% |
Jun 30, 2000 | 17.97M | 5.67M | 46.14% |
Jun 30, 1999 | 12.30M | -3.70M | -23.13% |
Jun 30, 1998 | 16.00M | 4.90M | 44.14% |
Jun 30, 1997 | 11.10M | 500.00K | 4.72% |
Jun 30, 1996 | 10.60M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 648.13B |
Costco | 248.83B |
PepsiCo | 91.88B |
Procter & Gamble | 84.06B |
Unilever | 66.23B |
Anheuser-Busch InBev | 59.38B |
The Coca-Cola Company | 46.07B |
Mondelez International | 36.14B |
INBP News
- 23 days ago - Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024 - Accesswire
- 3 months ago - Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023 - Accesswire
- 7 months ago - Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023 - Accesswire
- 9 months ago - Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023 - Accesswire
- 1 year ago - Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023 - Accesswire
- 1 year ago - Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President - Accesswire
- 1 year ago - Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022 - Accesswire
- 1 year ago - Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022 - Accesswire